Abstract
Breast cancers are highly variable with regard to pathological and clinical features. While various different cancers being at different stages of tumor progression might explain some of this variability, we must also consider evidence that breast cancers can also develop along different molecular pathways. This manuscript discusses the extensive heterogeneity of breast cancer at the pathological and molecular level, reviewing evidence for a breast cancer progression model as well as evidence that breast cancer is not a single disease. In addition to this heterogeneity among different breast cancers, there is often pathological and molecular heterogeneity among different areas within individual neoplasms. This heterogeneity within cancers probably reflects genetic instability, and could also explain the ability of breast cancers to adapt to new environmental situations. Understanding this heterogeneity, among different breast cancers as well as within individual cancers, is important for understanding the complexity of this disease and ultimately for managing breast cancer effectively.
Current Genomics
Title: Heterogeneity in the Pathology and Molecular Biology of Breast Cancer
Volume: 3 Issue: 5
Author(s): Edward Gabrielson and Pedram Argani
Affiliation:
Abstract: Breast cancers are highly variable with regard to pathological and clinical features. While various different cancers being at different stages of tumor progression might explain some of this variability, we must also consider evidence that breast cancers can also develop along different molecular pathways. This manuscript discusses the extensive heterogeneity of breast cancer at the pathological and molecular level, reviewing evidence for a breast cancer progression model as well as evidence that breast cancer is not a single disease. In addition to this heterogeneity among different breast cancers, there is often pathological and molecular heterogeneity among different areas within individual neoplasms. This heterogeneity within cancers probably reflects genetic instability, and could also explain the ability of breast cancers to adapt to new environmental situations. Understanding this heterogeneity, among different breast cancers as well as within individual cancers, is important for understanding the complexity of this disease and ultimately for managing breast cancer effectively.
Export Options
About this article
Cite this article as:
Gabrielson Edward and Argani Pedram, Heterogeneity in the Pathology and Molecular Biology of Breast Cancer, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350327
DOI https://dx.doi.org/10.2174/1389202023350327 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Current Pharmaceutical Design A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro
Anti-Cancer Agents in Medicinal Chemistry Smart Inulin-Based Polycationic Nanodevices for siRNA Delivery
Current Drug Delivery Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer
Current Protein & Peptide Science The Role of Vitamin D and Sunlight Incidence in Cancer
Anti-Cancer Agents in Medicinal Chemistry Novel Compounds from Marine Microorganisms that Inhibit Mammalian DNA Polymerase
Current Organic Chemistry Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design AMPK: Therapeutic Target for Diabetes and Cancer Prevention
Current Pharmaceutical Design Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Subject Index To Volume 4
Current Pharmacogenomics Clinical Trials with Intracerebral Convection-Enhanced Delivery of Targeted Toxins in Malignant Glioma
Reviews on Recent Clinical Trials Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors
Current Medicinal Chemistry Radiation Therapy Plus Angiogenesis Inhibition with Bevacizumab: Rationale and Initial Experience
Reviews on Recent Clinical Trials SUI-Current Medicinal Therapeutic Options
Current Women`s Health Reviews Unconventional Players on the Striated Muscle Field: microRNAs, Signaling Pathways and Epigenetic Regulators
Current Stem Cell Research & Therapy Brain Tumor Segmentation Using Deep Belief Networks and Pathological Knowledge
CNS & Neurological Disorders - Drug Targets Evaluation of the in vivo Safety Profiles of Rictor Inhibition Using a Zebrafish Model
Current Pharmaceutical Design Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity
Recent Patents on Anti-Cancer Drug Discovery Paris polyphylla: Chemical and Biological Prospectives
Anti-Cancer Agents in Medicinal Chemistry